← All Representatives

John Katko

House of Representatives · NY · former Representative

Terms: from 6 January 2015 to 8 December 2016 ; from 3 January 2017 to 21 December 2018 ; from 3 January 2019 to 28 December 2020 ; from 3 January 2021 to 23 December 2022

Participation in roll-call votes

98 % of the 4,474 roll-call votes held during their term: took part in the vote (for, against or abstention)

Participation month by month

0 % 50 % 100 % January 2015 : participation 94 % (45 / 48), presence 94 % (45 / 48) 2015 February 2015 : participation 98 % (55 / 56), presence 98 % (55 / 56) March 2015 : participation 100 % (38 / 38), presence 100 % (38 / 38) April 2015 : participation 100 % (63 / 63), presence 100 % (63 / 63) May 2015 : participation 98 % (55 / 56), presence 98 % (55 / 56) June 2015 : participation 98 % (124 / 126), presence 98 % (124 / 126) July 2015 : participation 100 % (100 / 100), presence 100 % (100 / 100) September 2015 : participation 100 % (39 / 39), presence 100 % (39 / 39) October 2015 : participation 100 % (51 / 51), presence 100 % (51 / 51) November 2015 : participation 100 % (64 / 64), presence 100 % (64 / 64) December 2015 : participation 100 % (60 / 60), presence 100 % (60 / 60) January 2016 : participation 98 % (43 / 44), presence 98 % (43 / 44) 2016 February 2016 : participation 98 % (56 / 57), presence 98 % (56 / 57) March 2016 : participation 100 % (36 / 36), presence 100 % (36 / 36) April 2016 : participation 90 % (37 / 41), presence 90 % (37 / 41) May 2016 : participation 100 % (89 / 89), presence 100 % (89 / 89) June 2016 : participation 99 % (73 / 74), presence 99 % (73 / 74) July 2016 : participation 96 % (130 / 136), presence 96 % (130 / 136) September 2016 : participation 99 % (95 / 96), presence 99 % (95 / 96) November 2016 : participation 100 % (19 / 19), presence 100 % (19 / 19) December 2016 : participation 100 % (29 / 29), presence 100 % (29 / 29) January 2017 : participation 100 % (67 / 67), presence 100 % (67 / 67) 2017 February 2017 : participation 100 % (39 / 39), presence 100 % (39 / 39) March 2017 : participation 98 % (98 / 100), presence 98 % (98 / 100) April 2017 : participation 100 % (28 / 28), presence 100 % (28 / 28) May 2017 : participation 96 % (47 / 49), presence 96 % (47 / 49) June 2017 : participation 98 % (58 / 59), presence 98 % (58 / 59) July 2017 : participation 100 % (94 / 94), presence 100 % (94 / 94) September 2017 : participation 100 % (105 / 105), presence 100 % (105 / 105) October 2017 : participation 96 % (46 / 48), presence 96 % (46 / 48) November 2017 : participation 100 % (58 / 58), presence 100 % (58 / 58) December 2017 : participation 87 % (53 / 61), presence 87 % (53 / 61) January 2018 : participation 100 % (48 / 48), presence 100 % (48 / 48) 2018 February 2018 : participation 90 % (37 / 41), presence 90 % (37 / 41) March 2018 : participation 66 % (25 / 38), presence 66 % (25 / 38) April 2018 : participation 100 % (37 / 37), presence 100 % (37 / 37) May 2018 : participation 100 % (64 / 64), presence 100 % (64 / 64) June 2018 : participation 95 % (79 / 83), presence 95 % (79 / 83) July 2018 : participation 100 % (66 / 66), presence 100 % (66 / 66) September 2018 : participation 100 % (36 / 36), presence 100 % (36 / 36) November 2018 : participation 90 % (9 / 10), presence 90 % (9 / 10) December 2018 : participation 99 % (74 / 75), presence 99 % (74 / 75) January 2019 : participation 100 % (63 / 63), presence 100 % (63 / 63) 2019 February 2019 : participation 58 % (22 / 38), presence 58 % (22 / 38) March 2019 : participation 100 % (33 / 33), presence 100 % (33 / 33) April 2019 : participation 94 % (33 / 35), presence 94 % (33 / 35) May 2019 : participation 100 % (60 / 60), presence 100 % (60 / 60) June 2019 : participation 98 % (196 / 199), presence 98 % (196 / 199) July 2019 : participation 100 % (84 / 84), presence 100 % (84 / 84) September 2019 : participation 100 % (41 / 41), presence 100 % (41 / 41) October 2019 : participation 100 % (54 / 54), presence 100 % (54 / 54) November 2019 : participation 97 % (32 / 33), presence 97 % (32 / 33) December 2019 : participation 92 % (54 / 59), presence 92 % (54 / 59) January 2020 : participation 100 % (33 / 33), presence 100 % (33 / 33) 2020 February 2020 : participation 100 % (44 / 44), presence 100 % (44 / 44) March 2020 : participation 100 % (24 / 24), presence 100 % (24 / 24) April 2020 : participation 100 % (2 / 2), presence 100 % (2 / 2) May 2020 : participation 100 % (11 / 11), presence 100 % (11 / 11) June 2020 : participation 61 % (11 / 18), presence 61 % (11 / 18) July 2020 : participation 96 % (43 / 45), presence 96 % (43 / 45) August 2020 : participation 100 % (4 / 4), presence 100 % (4 / 4) September 2020 : participation 97 % (30 / 31), presence 97 % (30 / 31) October 2020 : participation 100 % (5 / 5), presence 100 % (5 / 5) November 2020 : participation 100 % (9 / 9), presence 100 % (9 / 9) December 2020 : participation 96 % (25 / 26), presence 96 % (25 / 26) January 2021 : participation 94 % (15 / 16), presence 94 % (15 / 16) 2021 February 2021 : participation 100 % (31 / 31), presence 100 % (31 / 31) March 2021 : participation 96 % (46 / 48), presence 96 % (46 / 48) April 2021 : participation 100 % (36 / 36), presence 100 % (36 / 36) May 2021 : participation 100 % (23 / 23), presence 100 % (23 / 23) June 2021 : participation 100 % (48 / 48), presence 100 % (48 / 48) July 2021 : participation 100 % (50 / 50), presence 100 % (50 / 50) August 2021 : participation 100 % (6 / 6), presence 100 % (6 / 6) September 2021 : participation 100 % (52 / 52), presence 100 % (52 / 52) October 2021 : participation 93 % (25 / 27), presence 93 % (25 / 27) November 2021 : participation 96 % (47 / 49), presence 96 % (47 / 49) December 2021 : participation 100 % (61 / 61), presence 100 % (61 / 61) January 2022 : participation 100 % (13 / 13), presence 100 % (13 / 13) 2022 February 2022 : participation 100 % (34 / 34), presence 100 % (34 / 34) March 2022 : participation 98 % (53 / 54), presence 98 % (53 / 54) April 2022 : participation 95 % (37 / 39), presence 95 % (37 / 39) May 2022 : participation 99 % (90 / 91), presence 99 % (90 / 91) June 2022 : participation 100 % (67 / 67), presence 100 % (67 / 67) July 2022 : participation 100 % (118 / 118), presence 100 % (118 / 118) August 2022 : participation 100 % (3 / 3), presence 100 % (3 / 3) September 2022 : participation 95 % (54 / 57), presence 95 % (54 / 57) November 2022 : participation 100 % (14 / 14), presence 100 % (14 / 14) December 2022 : participation 100 % (58 / 58), presence 100 % (58 / 58)

Their votes

2,093 votes

DateTextResultTheir vote
H.R. 5055: Energy and Water Appropriations FY 2017 ✗ Rejected For
S. 2012: Energy Policy Modernization Act of 2016 ✓ Adopted For
H.R. 5233: Clarifying Congressional Intent in Providing for DC Home Rule Act of 2016 ✓ Adopted For
H.Res. 744: Providing for consideration of S. 2012, the Energy Policy Modernization Act of 2016; and providing for consideration of H.R. 5233, Clarifying Congressional Intent in Providing for DC Home Rule Act of 2016 ✓ Adopted For
H.R. 897: Zika Vector Control Act ✓ Adopted For
H.R. 5077: Intelligence Authorization Act for Fiscal Year 2017 ✓ Adopted For
H.Res. 742: Providing for consideration of the Senate amendment to the bill (H.R. 2576) to modernize the Toxic Substances Control Act, and for other purposes, and providing for consideration of the bill (H.R. 897) Reducing Regulatory Burdens Act, and for other purposes ✓ Adopted For
H.Res. 743: Providing for consideration of the bill (H.R. 5055) making appropriations for energy and water development and related agencies for the fiscal year ending September 30, 2017, and for other purposes ✓ Adopted For
H.R. 3998: Securing Access to Networks in Disasters Act ✓ Adopted For
H.R. 4889: Kelsey Smith Act ✗ Rejected For
H.R. 4974: Making appropriations for military construction, the Department of Veterans Affairs and related agencies for the fiscal year ending September 30, 2017, and for other purposes. ✓ Adopted For
H.R. 4909: National Defense Authorization Act for Fiscal Year 2017 ✓ Adopted For
H.R. 5243: Making appropriations for the fiscal year ending September 30, 2016, to strengthen public health activities in response to the Zika virus, and for other purposes ✓ Adopted For
H.Res. 736: Providing for consideration of H.R. 4974, the Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; and providing for consideration of H.R. 5243, the Zika Response Appropriations Act, 2016 ✓ Adopted For
H.Res. 735: Providing for further consideration of the bill (H.R. 4909) to authorize appropriations for fiscal year 2017 for military activities of the Department of Defense and for military construction, to prescribe military personnel strengths for such fiscal year, and for other purposes ✓ Adopted For
H.R. 897: Zika Vector Control Act ✗ Rejected For
H.Res. 732: Providing for consideration of the bill (H.R. 4909) to authorize appropriations for fiscal year 2017 for military activities of the Department of Defense and for military construction, to prescribe military personnel strengths for such fiscal year, and for other purposes ✓ Adopted For
H.R. 4407: Counterterrorism Advisory Board Act of 2016 ✓ Adopted For
H.R. 4743: National Cybersecurity Preparedness Consortium Act of 2016 ✓ Adopted For
S. 524: Comprehensive Addiction and Recovery Act of 2016 ✓ Adopted For
H.Res. 725: Providing for consideration of S. 524, the Comprehensive Addiction and Recovery Act of 2016 ✓ Adopted For
H.R. 4586: Lali’s Law ✓ Adopted For
H.R. 1818: Veteran Emergency Medical Technician Support Act of 2016 ✓ Adopted For
H.R. 5046: Comprehensive Opioid Abuse Reduction Act of 2016 ✓ Adopted For
H.R. 4843: Infant Plan of Safe Care Improvement Act ✓ Adopted For
H.R. 4641: To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes ✓ Adopted For
H.Res. 720: Providing for consideration of H.R. 4641, to provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes; and H.R. 5046, the Comprehensive Opioid Abuse Reduction Act of 2016 ✓ Adopted For
H.R. 5052: Opioid Program Evaluation Act ✓ Adopted For
H.R. 4957: To designate the Federal Building located at 99 New York Avenue, N.E., in the District of Columbia as the “Ariel Rios Federal Building” ✓ Adopted For
H.R. 4901: Scholarships for Opportunity and Results Reauthorization Act ✓ Adopted Absent
H.R. 2901: Flood Insurance Market Parity and Modernization Act ✓ Adopted For
H.J.Res. 88: Disapproving the rule submitted by the Department of Labor relating to the definition of the term “Fiduciary” ✓ Adopted For
H.R. 5019: Fair Access to Investment Research Act of 2016 ✓ Adopted For
H.Res. 706: Providing for consideration of H.R. 4901, the Scholarships for Opportunity and Results Reauthorization Act; and providing for consideration of H. J. Res. 88, disapproving the rule submitted by the Department of Labor relating to the definition of the term “Fiduciary” ✓ Adopted For
S. 1890: Defend Trade Secrets Act of 2016 ✓ Adopted For
H.R. 4498: Helping Angels Lead Our Startups (HALOS) Act ✓ Adopted For
H.Res. 701: Providing for consideration for H.R. 701, the Helping Angels Lead Our Startups Act ✓ Adopted For
H.R. 699: Email Privacy Act ✓ Adopted For
H.R. 4923: American Manufacturing Competitiveness Act of 2016 ✓ Adopted For
H.R. 4096: Investor Clarity and Bank Parity Act ✓ Adopted For

Rows per page: 20 40 100 200